首页> 美国卫生研究院文献>Annals of Thoracic and Cardiovascular Surgery >Epidermal Growth Factor Receptor Gene Mutation in Pleural Lavage Cytology Findings of Primary Lung Adenocarcinoma Cases
【2h】

Epidermal Growth Factor Receptor Gene Mutation in Pleural Lavage Cytology Findings of Primary Lung Adenocarcinoma Cases

机译:表皮生长因子受体基因突变在原发性肺腺癌病例的胸腔灌洗细胞学检查中的发现

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Purpose: In the present study, we examined the relationship between intraoperative pleural lavage cytology findings and presence of epidermal growth factor receptor (EGFR) gene mutations.Methods: We investigated 160 patients who underwent surgical treatment for primary lung adenocarcinoma at our hospital from January 2011 to December 2013 to determine the presence of EGFR gene mutations and pleural lavage cytology.Results: In all, 52 subjects (31.5%) were positive EGFR gene mutations, of whom 38 were found to possess the Exon 21 L858R mutation. Intraoperative pleural lavage cytology examinations were performed in 160 subjects and 12 had positive results, of whom 6 were positive for EGFR gene mutations, which was the Exon 21 L858R mutation in all. In a comparison between subjects possessing the Exon 21 L858R mutation and those negative for EGFR gene mutations, lavage cytology-positive (p = 0.02) and vascular infiltration-negative (p = 0.01) were characteristics of the Exon 21 L868R mutation-positive group.Conclusion: Subjects positive for the EGFR Exon 21 L858R mutation had a higher positive rate of intraoperative pleural lavage cytology than those not possessing EGFR mutations.
机译:目的:在本研究中,我们研究了术中胸膜灌洗液细胞学检查结果与表皮生长因子受体(EGFR)基因突变的存在之间的关系。方法:我们对2011年1月以来在本院接受手术治疗的160例原发性肺腺癌患者进行了调查结果:至2013年12月,确定是否存在EGFR基因突变和胸膜灌洗细胞学检查。结果:总共有52名受试者(31.5%)为EGFR基因阳性突变,其中38名具有Exon 21 L858R突变。术中对160名受试者进行了胸腔灌洗细胞学检查,其中12例阳性,其中6例EGFR基因突变为阳性,全部为Exon 21 L858R突变。在具有Exon 21 L858R突变的受试者与EGFR基因突变阴性的受试者之间的比较中,灌洗细胞学阳性(p = 0.02)和血管浸润阴性(p = 0.01)是Exon 21 L868R突变阳性组的特征。结论:EGFR Exon 21 L858R突变呈阳性的受试者比不具有EGFR突变的受试者具有更高的术中胸腔灌洗细胞学阳性率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号